EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Production and functional characteristics of a novel hirudin variant with better anticoagulant activities than bivalirudin

Peijuan Ge, Min Jin, Zimo Li, Licheng Zhu

Journal of Enzyme Inhibition and Medicinal Chemistry · 2025

DOI: 10.1080/14756366.2025.2554899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, 2025. Verfasst von Peijuan Ge und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Jinggangshan University, Ji'an, China. Hauptthemen laut MEDLINE: Hirudins, Anticoagulants, Peptide Fragments, Thrombin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Jiangxi Province, Key Laboratory of Jiangxi Province for Biological Invasion and Biosecurity, Key Laboratory of Jiangxi Province for Functional Biology and Pollution Control in Red Soil Regions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current antithrombotic therapies face dual constraints of bleeding complications and monitoring requirements. Although natural hirudin provides targeted thrombin inhibition, its clinical adoption is hindered by sourcing limitations. This study developed a recombinant hirudin variant HMg (rHMg) with enhanced anticoagulant activity through genetic engineering and established cost-effective large-scale production methods. The synthesised HMg gene was expressed in E. coli BL21 via a pET vector plasmid, followed by nickel-affinity purification. Systematic evaluations demonstrated rHMg's antithrombin activity of 9573 ATU/mg, dose-dependent prolongation of APTT/PT/TT. It has superior thrombin inhibition with the IC50 and Ki values were 2.8 and 0.323 nM respectively compared to FDA approved drug bivalirudin (p < 0.001). The high-yield prokaryotic expression of rHMg with enhanced anticoagulant efficacy provides a novel strategy for developing affordable antithrombotic drugs, showing significant potential for cardiovascular disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HirudinsAnticoagulantsPeptide FragmentsThrombinHumansDose-Response Relationship, DrugStructure-Activity RelationshipRecombinant ProteinsMolecular StructureEscherichia coli

Stichwörter der Autor:innen

Hirudinanticoagulationprokaryotic expressionthrombin inhibitor

Substanzen

HirudinsbivalirudinAnticoagulantsPeptide FragmentsRecombinant ProteinsThrombin

Autor:innen und Institutionen

  • School of Life Sciences, Jinggangshan University, Ji'an, China.
  • Key Laboratory of Jiangxi Province for Biological Invasion and Biosecurity, Jinggangshan University, Ji'an, China.

Förderung

  • Natural Science Foundation of Jiangxi Province
  • Key Laboratory of Jiangxi Province for Biological Invasion and Biosecurity
  • Key Laboratory of Jiangxi Province for Functional Biology and Pollution Control in Red Soil Regions

Zitieren

APA

Ge, P., Jin, M., Li, Z., & Zhu, L. (2025). Production and functional characteristics of a novel hirudin variant with better anticoagulant activities than bivalirudin. Journal of Enzyme Inhibition and Medicinal Chemistry. https://doi.org/10.1080/14756366.2025.2554899

Vancouver

Ge P, Jin M, Li Z, Zhu L. Production and functional characteristics of a novel hirudin variant with better anticoagulant activities than bivalirudin. Journal of Enzyme Inhibition and Medicinal Chemistry. 2025. doi:10.1080/14756366.2025.2554899

BibTeX
@article{Ge2025,
  author = {Ge, Peijuan and Jin, Min and Li, Zimo and Zhu, Licheng},
  title = {Production and functional characteristics of a novel hirudin variant with better anticoagulant activities than bivalirudin},
  journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
  year = {2025},
  doi = {10.1080/14756366.2025.2554899}
}
Kostenlos starten →